[Abstract Only] Randomized Trial: Ixekizumab for Patients with Non-radiographic Axial Spondyloarthritis

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial – The Lancet (link to abstract – $ for full-text)

Commentary: #VisualAbstract: Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X) – 2 Minute Medicine (free)

In this week's issue—Ixekizumab was superior to placebo for improving signs and symptoms in patients with non-radiographic axial spondyloarthritis at weeks 16 and 52: COAST-X, a randomised, placebo-controlled trial https://t.co/XuKDKGJns0 pic.twitter.com/bbuOReLCu2

— The Lancet (@TheLancet) January 8, 2020